|
1
|
Pawson T and Scott JD: Signaling through
scaffold, anchoring, and adaptor proteins. Science. 278:2075–2080.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burack WR and Shaw AS: Signal
transduction: hanging on a scaffold. Curr Opin Cell Biol.
12:211–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu J, Paquet M, Lau AG, Wood JD, Ross CA
and Hall RA: β1-adrenergic receptor association with the synaptic
scaffolding protein membrane associated guanylate kinase inverted-2
(MAGI2). Differential regulation of receptor internalization by
MAGI2 and PSD-95. J Biol Chem. 76:41310–41317. 2001.
|
|
4
|
Deng F, Price MG, Davis CF, Mori M and
Burgess DL: Stargazin and other transmembrane AMPA receptor
regulating proteins interact with synaptic scaffolding protein
MAGI2 in brain. J Neurosci. 26:7875–7884. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu Y, Li Z, Guo L, et al: MAGI2 inhibits
cell migration and proliferation via PTEN in human hepatocarcinoma
cells. Arch Biochem Biophys. 467:1–9. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirao K, Hata Y, Ide N, et al: A novel
multiple PDZ domain-containing molecule interacting with
N-methyl-D-aspartate receptors and neuronal cell adhesion
proteins. J Biol Chem. 273:21105–21110. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wood JD, Yuan J, Margolis RL, et al:
Atrophin-1, the DRPLA gene product, interacts with two families of
WW domain-containing proteins. Mol Cell Neurosci. 11:149–160. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nishimura W, Yao I, Iida J, Tanaka N and
Hata Y: Interaction of synaptic scaffolding molecule and β-catenin.
J Neurosci. 22:757–765. 2002.
|
|
9
|
Ide N, Hata Y, Deguchi M, Hirao K, Yao I
and Takai Y: Interaction of S-SCAM with neural plakophilin-related
Armadillo-repeat protein/delta-catenin. Biochem Biophys Res Commun.
256:456–461. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao I, Hata Y, Ide N, et al: MAGUIN, a
novel neuronal membrane-associated guanylate kinase-interacting
protein. J Biol Chem. 274:11889–11896. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu X, Hepner K, Castelino-Prabhu S, et al:
Evidence for regulation of the PTEN tumor suppressor by a
membrane-localized multi-PDZ domain containing scaffold protein
MAGI2. Proc Natl Acad Sci USA. 97:4233–4238. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Subbaiah VK, Kranjec C, Thomasm and Banks
L: PDZ domains: the building blocks regulating tumorigenesis.
Biochem J. 439:195–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morais Cabral JH, Petosa C, Sutcliffe MJ,
et al: Crystal structure of a PDZ domain. Nature. 382:649–652.
1996.PubMed/NCBI
|
|
14
|
Valiente M, Andrés-Pons A, Gomar B, et al:
Binding of PTEN to specific PDZ domains contributes to PTEN protein
stability and phosphorylation by microtubule-associated
serine/threonine kinases. J Biol Chem. 280:28936–28943. 2005.
View Article : Google Scholar
|
|
15
|
Subauste MC, Nalbant P, Adamson ED and
Hahn KM: Vinculin controls PTEN protein level by maintaining the
interaction of the adherens junction protein beta-catenin with the
scaffolding protein MAGI2. J Biol Chem. 280:5676–5681. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maehama T and Dixon JE: The tumor
suppressor, PTEN/MMAC1, dephosphorylates the lipid second
messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem.
273:13375–13378. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simpson L and Parsons R: PTEN: life as a
tumor suppressor. Exp Cell Res. 264:29–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Haas-Kogan D, Shalev N, Wonget M, Mills G,
Yount G and Stokoe D: Protein kinase B (PKB/AKT) activity is
elevated in glioblastoma cells due to mutation of the tumor
suppressor PTEN/MMAC. Curr Biol. 8:1195–1198. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li DM and Sun H: PTEN/MMAC1/TEP1
suppresses the tumorigenicity and induces G1 cell cycle arrest in
human glioblastoma cells. Proc Natl Acad Sci USA. 95:15406–15411.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Yang H, Liu H, Huang J and Song X:
Effect of staurosporine on the mobility and invasiveness of lung
adenocarcinoma A549 cells: an in vitro study. BMC Cancer.
9:1742009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gescher A: Analogs of staurosporine:
potential anticancer drugs? Gen Pharmacol. 31:721–728. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Yu S, Ou-Yang J, Xia D, Wang M
and Li J: Effect of protein kinase C alpha, caspase-3, and survivin
on apoptosis of oral cancer cells induced by staurosporine. Acta
Pharmacol Sin. 26:1365–1372. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fesus L, Davies PJ and Piacentini M:
Apoptosis: molecular mechanisms in programmed cell death. Eur J
Cell Biol. 56:170–177. 1991.PubMed/NCBI
|
|
24
|
Thornberry NA, Rano TA, Peterson EP, et
al: A combinatorial approach defines specificities of members of
the caspase family and granzyme B. Functional relationships
established for key mediators of apoptosis. J Biol Chem.
272:17907–17911. 1997. View Article : Google Scholar
|
|
25
|
Sonoda Y, Ozawa T, Aldape KD, Deen DF,
Berger MS and Pieper RO: AKT pathway activation converts anaplastic
astrocytoma to glioblastoma multiforme in a human astrocyte model
of glioma. Cancer Res. 61:6674–6678. 2001.PubMed/NCBI
|
|
26
|
Ta HQ, Thomas KS, Schrecengost RS and
Bouton AH: A novel association between p130Cas and resistance to
the chemotherapeutic drug adriamycin in human breast cancer cells.
Cancer Res. 68:8796–8804. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stambolic V, Suzuki A, de la Pompa JL, et
al: Negative regulation of PKB/AKT-dependent cell survival by the
tumor suppressor PTEN. Cell. 95:29–39. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun H, Lesche R, Li DM, et al: PTEN
modulates cell cycle progression and cell survival by regulating
phosphatidylinositol 3,4,5,-trisphosphate and AKT/protein kinase B
signaling pathway. Proc Natl Acad Sci USA. 96:6199–6204. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brunet A, Datta SR and Greenberg ME:
Transcription-dependent and -independent control of neuronal
survival by the PI3K-AKT signaling pathway. Curr Opin Neurobiol.
11:297–305. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dudek H, Datta SR, Franke TF, et al:
Regulation of neuronal survival by the serine-threonine protein
kinase AKT. Science. 275:661–665. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Franke TF, Kaplan DR and Cantley LC: PI3K:
downstream AKTion blocks apoptosis. Cell. 88:435–437. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kauffmann-Zeh A, Rodriguez-Viciana P,
Ulrich E, Gilbert C, Coffer P, Downward J and Evan G: Suppression
of c-Myc-induced apoptosis by Ras signalling through PI(3)K and
PKB. Nature. 385:544–548. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kulik G, Klippel A and Weber MJ:
Antiapoptotic signalling by the insulin-like growth factor I
receptor, phosphatidylinositol 3-kinase, and AKT. Mol Cell Biol.
17:1595–1606. 1997.PubMed/NCBI
|
|
34
|
Chen RH, Su YH, Chuang RL and Chang TY:
Suppression of transforming growth factor-beta-induced apoptosis
through a phosphatidylinositol 3-kinase/AKT-dependent pathway.
Oncogene. 17:1959–1968. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gibson S, Tu S, Oyer R, Anderson SM and
Johnson GL: Epidermal growth factor protects epithelial cells
against Fas-induced apoptosis. Requirement for AKT activation. J
Biol Chem. 274:17612–17618. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
González-Mariscal L, Betanzos A and
Avila-Flores A: MAGUK proteins: structure and role in the tight
junction. Semin Cell Dev Biol. 11:315–324. 2000.PubMed/NCBI
|
|
37
|
Lehtonen S, Ryan JJ, Kudlicka K, Iino N,
Zhou H and Farquhar MG: Cell junction-associated proteins IQGAP1,
MAGI-2, CASK, spectrins, and β-actinin are components of the
nephrin multiprotein complex. Proc Natl Acad Sci USA.
102:9814–9819. 2005.PubMed/NCBI
|
|
38
|
Tsunoda S, Sierralta J, Sun Y, et al: A
multivalent PDZ-domain protein assembles signalling complexes in a
G-protein-coupled cascade. Nature. 388:243–249. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tolkacheva T, Boddapati M, Sanfiz A,
Tsuchida K, Kimmelman AC and Chan AM: Regulation of PTEN binding to
MAGI2 by two putative phosphorylation sites at threonine 382 and
383. Cancer Res. 61:4985–4989. 2001.PubMed/NCBI
|
|
40
|
Planchon SM, Waite KA and Eng C: The
nuclear affairs of PTEN. J Cell Sci. 121:249–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
